Marco Pappagallo
Corporate Officer/Principal bei Sapienza University of Rome
Profil
Marco Pappagallo is the founder of Novapharm Therapeutics, which was founded in 2010.
He held the title of Chief Medical Officer at Novapharm Therapeutics.
Currently, Dr. Pappagallo is a Professor at Sapienza University of Rome.
In the past, he worked as the Director-Chronic Pain at Beth Israel Medical Center, The Johns Hopkins University, and Icahn School of Medicine at Mount Sinai.
He also served as the Director-Pain Research & Professor-Anesthesiology at The Mount Sinai Medical Center, Inc. Additionally, Dr. Pappagallo worked as the Executive Director-Medical Intelligence at Grünenthal USA, Inc. and as a Professor at Albert Einstein College of Medicine, Inc. He was also the Chief Medical Officer at Cersci Therapeutics, Inc. Currently, Dr. Pappagallo is the Chief Clinical Officer at Relmada Therapeutics, Inc. from 2020 to 2023.
Dr. Pappagallo obtained a doctorate degree from The American University of Rome.
Aktive Positionen von Marco Pappagallo
Unternehmen | Position | Beginn |
---|---|---|
Sapienza University of Rome | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Marco Pappagallo
Unternehmen | Position | Ende |
---|---|---|
RELMADA THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2023 |
Albert Einstein College of Medicine, Inc. | Corporate Officer/Principal | 01.01.2014 |
The Mount Sinai Medical Center, Inc.
The Mount Sinai Medical Center, Inc. Hospital/Nursing ManagementHealth Services The Mount Sinai Medical Center, Inc. operates charitable teaching hospitals. The non-profit company is based in New York, NY. The CEO of the company is Gino Santorio. | Corporate Officer/Principal | - |
The Johns Hopkins University | Corporate Officer/Principal | - |
Icahn School of Medicine at Mount Sinai | Corporate Officer/Principal | - |
Ausbildung von Marco Pappagallo
The American University of Rome | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
RELMADA THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 5 |
---|---|
Cersci Therapeutics, Inc.
Cersci Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cersci Therapeutics, Inc. operates as pharmaceutical company. The firm develops non-opioid analgesic drug products without the deleterious side effects. The company was founded by Lucas Rodriguez and Brent Duncan in 2019 and is headquartered in Dallas, TX. | Health Technology |
Grünenthal USA, Inc.
Grünenthal USA, Inc. Pharmaceuticals: MajorHealth Technology Grünenthal USA, Inc. is a pharmaceutical company based in Morristown, NJ. The private company manufactures and distributes pharmaceutical products. | Health Technology |
Novapharm Therapeutics | |
Beth Israel Medical Center
Beth Israel Medical Center Hospital/Nursing ManagementHealth Services Beth Israel Medical Center provided health care services. The firm operates outpatient care center. The company was headquartered in New York, NY. | Health Services |
The Mount Sinai Medical Center, Inc.
The Mount Sinai Medical Center, Inc. Hospital/Nursing ManagementHealth Services The Mount Sinai Medical Center, Inc. operates charitable teaching hospitals. The non-profit company is based in New York, NY. The CEO of the company is Gino Santorio. | Health Services |